Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has announced the sale of a 49% stake in its joint venture with Nestlé India, forming ‘Dr. Reddy’s and Nestlé Health Science Limited.’ The transaction, which sees Nestlé India acquiring these shares, leaves Dr. Reddy’s with a 51% majority stake. The move is part of a strategic joint venture agreement aimed at bolstering the companies’ positions in the health science sector.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
